AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05042323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TF-CBT-Short
Description: Participants receive either 4-5 sessions of TF-CBT-Skills or TF-CBT-Narr. If the participant still has significant PTSS they are provided with step two which is the components provided in the arm they did not receive.
Study NCT06028152 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: End-of-life conversation game called Hello
Description: To play 'Hello', players are provided 32 open-ended questions in a prearranged order and an equal number of game chips. A player reads aloud the first question. Players then individually write down their answers, and take turns sharing answers with the group (players can opt to pass). Players control how long they share, what they share, and when they are ready to proceed to the next question. During the conversation, players may choose to acknowledge others for a particularly thoughtful, poignant, or even funny comment by giving them a chip. A simple pre-game coin flip determines whether the player with the most chips 'wins' the game ('heads'), or the player with the least amount of chips wins the game ('tails').~Other Name: Previously named My Gift of Grace
Study NCT06538051 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: lying positions
Description: All patients were placed in supine, semi-fowler's and lateral positions, respectively. The effects of positions on hemodynamic parameters were examined.
Study NCT05923606 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tACS
Description: Placebo tACS will be administered over the left dorsolateral prefrontal cortex for approximately 25 minutes.
Study NCT04726449 — intervention group
Intervention type: OTHER
Intervention: Screening for acute confusional state
Description: The intervention will consist of two psychometric test to screen for acute confusional state with the usual physical examination by the emergency physician. The neurological examination abnormalities will be noted
Study NCT06152640 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deep transcranial magnetic stimulation
Description: Neuronavigation: The coil is positioned 4cm in front of the scalp point and foot motor cortex, corresponding to the ACC. The Brainways H7 coil with fluid cooling is used to obtain a greater depth of stimulation, up to about 6 cm below the cortex.~dTMS intervention: The intervention targets are at the left and right ACC, once per day, for 28 days. A total of 28 treatments are given. Stimulation mode: stimulation frequency 1Hz, stimulation intensity 100% RMT, number of pulses 150, sequence interval 20s, total 6 trials, 900 pulses.
Study NCT06152640 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham deep transcranial magnetic stimulation
Description: Neuronavigation: The sham coil is positioned 4 cm in front of the scalp point and foot motor cortex, corresponding to the ACC.~Sham dTMS intervention: The intervention targets are at the left and right ACC (The sham coil has the same parameters as real dTMS and generating the same noise as real coils, but without the magnetic field), once per day, for 28 days. A total of 28 treatments are given.
Study NCT06152640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Basic treatment
Description: According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal. Both groups received the same nutritional treatment.
Study NCT06152640 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Basic treatment
Description: According to national and international guidelines for the treatment of eating disorders, the basic treatment for patients is nutritional therapy, that is, regular and quantitative dietary treatment, with three regular meals followed by a snack meal 2 hours after the regular meal. Both groups received the same nutritional treatment.
Study NCT04761042 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WAYA-Wilderness
Description: The wilderness intervention includes challenging tasks in order to help participants' overcome and master new physical and psychological challenges in an unknown environment, with the idea to support self-efficacy, self-esteem, and ability to recover from adversity. The program is designed to encourage participants to connect with nature as to experience gratitude for the richness of the natural world, a sense of calmness and trust upon spending time in nature, and to be more physically active in nature.~Elements previously described Participants will continue in a three-month program at home (on-line supported) after the initial 8-days in order to empower participants to incorporate elements of the onsite wilderness program into their daily life. An individualized a plan for activities will be developed together with the participant.~After three months, there will be a re-visit with follow up on outcome measures and reconnection.
Study NCT04761042 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: WAYA-Holiday
Description: An attention control group (information in Detailed description)
Study NCT05551286 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A rehabilition programme for young adult cancer survivors
Description: The programme consists of 22 sessions focusing on; 1) everyday life (energy conservation, cognitive challenges, fatigue); 2) Physical activity; 3) psychological issues; 4) work and study d; 5) sexuality and relationship; 7) rights and finance, and 8) goal setting. The sessions include both education, workshops, and engagement in different activities and will be delivered by a multidisciplinary team.
Study NCT05408624 — intervention group
Intervention type: PROCEDURE
Intervention: ultrasound transvaginal drainage
Description: Ultrasound-guided transvaginal drainage of TOA by a puncture under simple sedation or analgesia with/or under general anesthesia
Study NCT05408624 — intervention group
Intervention type: PROCEDURE
Intervention: laparoscopy
Description: Laparoscopy for drainage of TOA under general anesthesia
Study NCT05210582 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afamelanotide
Description: Patients will receive afamelanotide over a three-month period, with an additional three-month follow up.
Study NCT05790798 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: occupational therapy-based instrumental daily living activities intervention
Description: Occupational therapy-based instrumental activities of daily living intervention were applied to 9 people with disabilities in the intervention group, with sessions consisting of 45 minutes twice a week (totally 8 weeks/16 sessions). While the activity intervention program was being created for the intervention group, the problem areas in the ADL and IADL determined by the evaluations made before the intervention were identified. Ten occupation kits including 2 ADLs (dressing and feeding nutrition), and 8 IADLs (laundry, meal preparation, light cleaning, paperwork, use of technology, lifting and carrying, fine motor and gross motor leisure groups) were used as interventions. Various materials (jar, shirt, spoon, teapot, play dough, stapler, plastic bag, sponge, etc.) were prepared to be used in each occupation kit and to simulate daily activities.
Study NCT05790798 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quite recreation activity
Description: For the control group, information about the scope, duration and requirements of the research was shared throughout the process. During this period, reading activities continued. The final evaluation of all participants was made at the end of the 8th week of the study and the study was completed.
Study NCT05742932 — intervention group
Intervention type: DEVICE
Intervention: Trauma surgery using Global D's implants.
Description: Major or minor participants who will be treated by an trauma surgery with ORTRAUTEK® or MINITEK/MICROTEK® implant(s).
Study NCT04811924 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Application of 0.02% MMC over 60 seconds post corneal crosslinking.
Description: Topical application of 0.02% MMC on the surface of the cornea post CXL. The surface of the eye is washed thoroughly with Balanced Salt Solution (BSS) over 1 minute after MMC application.
Study NCT04811924 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Corneal crosslinking without the application of 0.02% MMC
Description: Topical application of placebo on the surface of the cornea post CXL. The surface of the eye is washed thoroughly with Balanced Salt Solution (BSS) over 1 minute after placebo application.
Study NCT05055700 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app with prenatal genetic testing information
Description: In the intervention group, participants will be asked to download, register, and review a mobile app on their own mobile phones before their appointment with maternal-fetal medicine specialists. This mobile app includes prenatal genetic testing information about amniocentesis, chorionic villus sampling, nuchal translucency screening, cell-free DNA, triple/quad/penta screening, anatomy ultrasound, and carrier screening.
Study NCT05491135 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HMB002
Description: The solution containing microbeads will be infused manually into the peritoneal cavity under ultrasound guidance, with usually a 50ml syringe, as a single infusion or several infusions, to achieve in excess of 25 million hepatocytes per kilogram of the body weight.
Study NCT06552143 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Stone needle therapy follows the Belt channel
Description: Stone needle therapy follows the Belt channel involves the use of stones by the intervener to follow the path of the Belt channel by pushing and rubbing the abdomen of patients with postpartum diastasis rectus abdominis.
Study NCT06457516 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Mirror Therapy
Description: A mirror is used to create a reflective illusion of an affected limb in order to trick the brain into thinking movement has occurred without pain, or to create positive visual feedback of a limb movement. It involves placing the affected limb behind a mirror.
Study NCT06457516 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Music Therapy
Description: Music therapy, an allied health profession, the clinical and evidence-based use of music interventions to accomplish individualized goals
Study NCT06378606 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive therapy
Description: intervention : group A: recive computer cognitive traing by rehacom system and omega 3 supplement .~group B: recive smart phone cognitive application and omega 3 supplement . group c recive omega 3 supplement only.
Study NCT06378606 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive therapy
Description: intervention : group A: recive computer cognitive traing by rehacom system and omega 3 supplement .~group B: recive smart phone cognitive application and omega 3 supplement . group c recive omega 3 supplement only.
Study NCT06378606 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: cognitive therapy
Description: intervention : group A: recive computer cognitive traing by rehacom system and omega 3 supplement .~group B: recive smart phone cognitive application and omega 3 supplement . group c recive omega 3 supplement only.
Study NCT05164783 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Sanacoach Parkinson (SCP)
Description: A web-based monitoring tool for patients with PD, using questionnaires. It includes nine parts: 1) A 89-question, quarterly questionnaire about PD-symptoms. 2) Questionnaire responses are converted to scores on 16 PD-related domains. Both the current score and the score's change compared to the previous questionnaire are visible. 3) An interim evaluation is sent after 6 weeks with questions on any domains where a patient indicated problems. 4) A medication monitor can be initialized by the treating physician to evaluate the effect of a therapeutic change. 5) A consultation preparation module allows patients to indicate which topics they want to discuss during an outpatient visit. 6) Patients can ask for 'calling advise' if they are unsure whether to contact their physician. 7) Patients and healthcare providers can send each other text messages. 8) Interactive learning modules about PD. 9) Annual evaluation regarding patient satisfaction, self-management and healthcare consumption.
Study NCT05379673 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen Gas for Inhalation
Description: Oxyhemoglobin saturation (SpO2) higher than 96% vs SpO2 between 90% and 94%.
Study NCT05379673 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oxygen Gas for Inhalation
Description: Oxyhemoglobin saturation (SpO2) higher than 96% vs SpO2 between 90% and 94%.
Study NCT04823975 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Insurance Education Program (HIEP)
Description: \[See arm/group description\]
Study NCT05055050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UGN-201
Description: Intravesical 200 mg /50 ml x 1 dose
Study NCT06621004 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patients will receive propranolol 1-2 mg.
Description: Patients will receive propranolol 1-2 mg. prepared in a 10 ml syringe (100 ug/ml).
Study NCT06621004 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Patient receives magnesium sulphate
Description: Magnesium sulphate 10%: 1g ampoule (10ml), will be prepared in a syringe pump to be given at a rate of 40 ml/hr . Another syringe of 10 ml 0.9% sodium chloride will be prepared to be given in group (P).
Study NCT06600126 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping Skills Training
Description: The Coping Skills Training arm will consist of 12 weekly 30-minute sessions via videoconferencing or phone. A trained research staff member will deliver sessions that focus on building coping skills for patients with COPD, such as progressive relaxation training, pleasant activity scheduling, and building communication skills. Caregivers will also participate, learning how to support the patient in using these skills. Participants will complete assignments between sessions to reinforce their learning. Additionally, participants will receive a Coping Skills Training workbook.
Study NCT06600126 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COPD Education
Description: The COPD Education arm will consist of 12 weekly 10-minute sessions via videoconferencing or phone. A trained research staff member will provide scripted general support and encouragement without using specific psychoeducational techniques. Caregivers will also participate. Additionally, participants will receive a COPD Education workbook with material from The COPD Foundation, which is also available on the Foundation's website. This program augments usual care, providing an attention control for comparison.
Study NCT06625632 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antiemetic Drug
Description: All participants in the two groups will receive antiemetic drugs (ondansetron 4 mg) every 12 hours, for 5 days.
Study NCT06625632 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antiemetic Drug
Description: All participants in the two groups will receive antiemetic drugs (ondansetron 4 mg) every 12 hours, for 5 days.
Study NCT06625632 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin B6
Description: All participants in the two groups will receive vitamin B6 (50 mg), once daily, for 5 days.
Study NCT06625632 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin B6
Description: All participants in the two groups will receive vitamin B6 (50 mg), once daily, for 5 days.
Study NCT06625632 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home care advice
Description: All participants in both groups will be advised to eat small portions of food, drink plenty of liquids, and avoid fatty and fried foods. Additionally, they should steer clear of highly spiced foods, foods and beverages with strong odors, caffeine, and consume neither very hot nor very cold foods and liquids.
Study NCT06625632 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home care advice
Description: All participants in both groups will be advised to eat small portions of food, drink plenty of liquids, and avoid fatty and fried foods. Additionally, they should steer clear of highly spiced foods, foods and beverages with strong odors, caffeine, and consume neither very hot nor very cold foods and liquids.
Study NCT06625632 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: It will be applied for all participants in the experimental group only for 5 days. The participant will be asked to stand in erect position, her hands beside her body then applying the kinesiotape from origin (from top to bottom where the stomach is placed on the abdominal region) to insertion (alongside the gastric curvature) with tension 25% for 5 days.
Study NCT06628557 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients
Description: The Effect of Mandala Art Therapy on Anxiety and Pain in Patients
Study NCT06633939 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral Treatment
Description: The theoretical framework for the Move \&amp; Eat 2 Live intervention is guided by the health belief model (HBM), socioecological model (SEM) and motivational interviewing (MI) approach. Tailoring to the target community will include a standard cultural adaptation that will replace curriculum content and examples with Native American relevant foods, physical activities, and representation in materials. For this study, the intervention will be piloted in the target population and will include the first 5 sessions of the original 12-session program.
Study NCT06633315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low dos dexmedetomidine
Description: received dexmedetomidine 2.5 μ g/kg nasal drops
Study NCT06633315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high dos dexmedetomidine
Description: received dexmedetomidine 3 μ g/kg nasal drops
Study NCT06633315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dexmedetomidine and esketamine
Description: received dexmedetomidine 2 μ g/kg nasal drops plus ketamine 0.5 mg/kg nasal drops
Study NCT05177718 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Natalizumab 300 MG in 15 ML Injection
Description: Disease modifying agent
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Description: 24-question sleep quality assessment scale, a score > 5 indicates poor sleep quality
Study NCT04771923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Topical instillation of tranexamic acid up to 3x. If bleeding is not controlled patients crossover to adrenaline.
Study NCT04771923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adrenaline
Description: Topical instillation of adrenaline up to 3x. If bleeding is not controlled patients crossover to tranexamic acid.
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Epworth questionnaire
Description: 8-question sleepiness assessment scale, a score above 10 indicates excessive sleepiness
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epworth questionnaire
Description: 8-question sleepiness assessment scale, a score above 10 indicates excessive sleepiness
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The Karolinska Sleepiness Scale
Description: The Karolinska Sleepiness Scale measures daytime sleepiness on a 9-point scale, based on 5 states and 4 intermediate states that are not verbally indicated.
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Karolinska Sleepiness Scale
Description: The Karolinska Sleepiness Scale measures daytime sleepiness on a 9-point scale, based on 5 states and 4 intermediate states that are not verbally indicated.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Actimeter
Description: An actimeter will be worn on the non-dominant wrist, uninterrupted day and night, for 7 consecutive days.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Actimeter
Description: An actimeter will be worn on the non-dominant wrist, uninterrupted day and night, for 7 consecutive days.
Study NCT06180070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen/ Paracetamol tablets
Description: 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol
Study NCT06180070 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen/ Paracetamol tablets
Description: 1 tablet of 200mg Ibuprofen/ 500mg Paracetamol
Study NCT05844943 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReHeal glove with Negative Pressure Wound Therapy (NPWT)
Description: ReHeal glove hand dressing with Negative Pressure Wound Therapy (NPWT).
Study NCT05841277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3819469
Description: Administered SC.
Study NCT05327244 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Real-world vibration feedback gait retraining
Description: Participants will walk with a vibration feedback tool attached to their shoelaces. A small force sensing resistor is taped to the foot bed of the shoe under the lateral foot and a vibration motor is placed over the outside of the ankle with a strap. When a participant walks on the outside of their foot, they will exceed the pressure threshold and activate the feedback which signifies an incorrect foot placement. The feedback is intended to prompt a correct foot placement on the subsequent step. Participants will use the same feedback tool for 6 real world training sessions.